JPMorgan analyst Sebastiano Petti maintained an Overweight rating on United States Cellular (NYSE:USM) and lowered the price forecast from $88 to $85. The analyst says that he foresees additional ...
There are hundreds of diseases affecting humans that result from errors in cellular production of its proteins. A team led by researchers at the University of Massachusetts, Amherst, report they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback